UBS Group
MLSS icon

UBS Group’s Milestone Scientific MLSS Stock Holding History

UBS Group’s Portfolio MLSS Stock Details MLSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18K Sell
62,500
-33,428
-35% -$9.34K ﹤0.01% 8009
2025
Q4 		$26.2K Buy
95,928
+90,942
+1,824% +$34.6K ﹤0.01% 7605
2025
Q3 		$2.26K Sell
4,986
-8,114
-62% -$4.75K ﹤0.01% 9194
2025
Q2 		$8.33K Buy
13,100
+8,114
+163% +$7.44K ﹤0.01% 8956
2025
Q1 		$4.65K Hold
4,986
– – ﹤0.01% 9083
2024
Q4 		$4.79K Buy
4,986
+4,642
+1,349% +$3.83K ﹤0.01% 8726
2024
Q3 		$313 Buy
+344
New +$323 ﹤0.01% 9002
2024
Q2 		– Sell
-7,246
Closed -$4.51K – 9885
2024
Q1 		$4.51K Sell
7,246
-29,595
-80% -$19.4K ﹤0.01% 7616
2023
Q4 		$25.4K Buy
36,841
+24,868
+208% +$19.8K ﹤0.01% 6949
2023
Q3 		$11K Buy
11,973
+5,034
+73% +$5.3K ﹤0.01% 7077
2023
Q2 		$6.04K Buy
6,939
+2,673
+63% +$2.41K ﹤0.01% 7403
2023
Q1 		$3.84K Hold
4,266
– – ﹤0.01% 8270
2022
Q4 		$2.05K Sell
4,266
-2,513
-37% -$1.63K ﹤0.01% 9742
2022
Q3 		$5K Buy
6,779
+2,513
+59% +$2.44K ﹤0.01% 9205
2022
Q2 		$4K Sell
4,266
-742
-15% -$756 ﹤0.01% 9088
2022
Q1 		$7K Buy
5,008
+742
+17% +$1.08K ﹤0.01% 8828
2021
Q4 		$9K Hold
4,266
– – ﹤0.01% 8918
2021
Q3 		$8K Sell
4,266
-7,599
-64% -$14.1K ﹤0.01% 8210
2021
Q2 		$29K Sell
11,865
-6,000
-34% -$14.6K ﹤0.01% 6978
2021
Q1 		$64K Buy
17,865
+2,522
+16% +$8.64K ﹤0.01% 6312
2020
Q4 		$32K Buy
15,343
+8,619
+128% +$15.2K ﹤0.01% 6577
2020
Q3 		$9K Sell
6,724
-8,739
-57% -$15.2K ﹤0.01% 6940
2020
Q2 		$30K Buy
15,463
+1,395
+10% +$2.55K ﹤0.01% 6270
2020
Q1 		$18K Buy
14,068
+9,569
+213% +$17.3K ﹤0.01% 6556
2019
Q4 		$6K Hold
4,499
– – ﹤0.01% 7518
2019
Q3 		$4K Hold
4,499
– – ﹤0.01% 7557
2019
Q2 		$2K Sell
4,499
-3,793
-46% -$1.38K ﹤0.01% 7622
2019
Q1 		$2K Sell
8,292
-52,104
-86% -$19.1K ﹤0.01% 7455
2018
Q4 		$20K Buy
60,396
+49,897
+475% +$26.7K ﹤0.01% 6791
2018
Q3 		$8K Hold
10,499
– – ﹤0.01% 7281
2018
Q2 		$8K Sell
10,499
-1,151
-10% -$898 ﹤0.01% 7260
2018
Q1 		$9K Sell
11,650
-7,413
-39% -$7.15K ﹤0.01% 6939
2017
Q4 		$22K Buy
19,063
+8,564
+82% +$10.1K ﹤0.01% 6480
2017
Q3 		$13K Sell
10,499
-4,188
-29% -$5.46K ﹤0.01% 6736
2017
Q2 		$22K Buy
14,687
+4,188
+40% +$5.85K ﹤0.01% 6228
2017
Q1 		$14K Sell
10,499
-12,392
-54% -$17.3K ﹤0.01% 6407
2016
Q4 		$32K Buy
22,891
+18,392
+409% +$32.2K ﹤0.01% 6181
2016
Q3 		$10K Hold
4,499
– – ﹤0.01% 6786
2016
Q2 		$13K Sell
4,499
-445
-9% -$1.02K ﹤0.01% 6621
2016
Q1 		$8K Buy
4,944
+445
+10% +$805 ﹤0.01% 6787
2015
Q4 		$11K Hold
4,499
– – ﹤0.01% 7229
2015
Q3 		$14K Sell
4,499
-997
-18% -$3.05K ﹤0.01% 7019
2015
Q2 		$18K Buy
+5,496
New +$19.2K ﹤0.01% 6976

Other funds holding MLSS

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return
CIC
Carnegie Investment Counsel Pepper Pike, Ohio $4.99B AUM 23.08% 1-Year Est. Return

UBS Group's MLSS Position: Q1 2026 in Review

UBS Group reduced its Milestone Scientific (MLSS) stake by 35% in Q1 2026, selling an estimated $9.34K and leaving 62,500 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #8009.

UBS Group first reported a position in MLSS in Q2 2015 and has held it in 43 quarters since. The position peaked at $64K in Q1 2021. 32 funds tracked by Wall St. Rank hold MLSS as of Q1 2026.

  • UBS Group held 62,500 shares of Milestone Scientific worth $18K as of Q1 2026.
  • UBS Group sold 33,428 Milestone Scientific shares in Q1 2026, an estimated $9.34K.
  • Milestone Scientific made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8009 holding.
  • UBS Group first reported a position in Milestone Scientific in Q2 2015 and has held it in 43 quarters since.
  • UBS Group's Milestone Scientific position peaked at $64K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Milestone Scientific as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.